Multiple system atrophy (MSA) is a progressive neurodegenerative disease variably
associated with motor, nonmotor, and autonomic symptoms, resulting from putaminal and …

Multiple system atrophy (MSA) is a rare neurodegenerative disorder without any effective
treatment in slowing or stopping disease progression. It is characterized by poor levodopa …

Abstract Purpose of Review This review summarizes previous and ongoing neuroprotection
trials in multiple system atrophy (MSA), a rare and fatal neurodegenerative disease …

Multiple system atrophy (MSA) is a fatal orphan neurodegenerative disorder that manifests
with rapidly progressive autonomic and motor dysfunction. The disease is characterized by …

Multiple system atrophy is a rare, debilitating, adult-onset neurodegenerative disorder that
manifests clinically as a diverse combination of parkinsonism, cerebellar ataxia, and …

Multiple system atrophy (MSA) is a rare, severe, and rapidly progressive neurodegenerative
disorder categorized as an atypical parkinsonian syndrome. With a mean life expectancy of …

Multiple system atrophy is a rapidly progressive and fatal neurodegenerative disorder. While
numerous preclinical studies suggested efficacy of potentially disease modifying agents …

Multiple system atrophy (MSA) is a sporadic, adult onset, relentlessly progressive
neurodegenerative disease characterized by autonomic abnormalities associated with …

Over the last decade a prominent amount of studies in preclinical transgenic models of
multiple system atrophy (MSA) has been performed. These studies have helped understand …

Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder characterized
by a variable combination of parkinsonism, cerebellar impairment, and autonomic …